Need Help? Call 1­-866-­796-­7386
« back to stock screener

  ALXN stock: Alexion Pharmaceuticals, Inc.

Current Rating
Strong Sell

Previous Rating:

Strong Sell
Our Stock Ratings
double the S&P500!
Learn more.
Company Statistics
Price
$128.82
Market Cap
28.94B
Sector
Health Care
Div. Growth
-
P/E
78.5
P/B
3.41
P/S
9.81
Dividend %
-
P/CF
-
P/FCF
50.3
Op. Cash Flow
871.3K
FCF
2.5
Op. Margin
23.90%
Net Margin
13.50%
ROE
4.80%
ROI
1.60%
ROA
3.10%
EPS Growth
41.10%
Current Ratio
3.4
Debt/Equity
39.40%
Company Price P/E Div. Yield Market Cap ($Mil) Rating
Merus Labs International Inc ( (MSLI) $0.86 - - 93.4M Strong Buy
Polydex Pharmaceuticals Ltd (POLXF) $1.06 - - 6.2M Strong Buy
Biomerica, Inc. (BMRA) $2.65 - - 23.3M Strong Buy
Pen Inc (PENC) $1.55 - - 5.4M Strong Buy
Spine Injury Solutions Inc (SPIN) $0.44 - - 4.6M Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More